Tumor-induced perturbations of cytokines and immune cell networks

Brett Burkholder1, Ren-Yu Huang2, Rob Burgess1

  • 1RayBiotech, Inc., 3607 Parkway Lane, Suite 100, Norcross, GA 30092, USA.

Insights

Tumor cells evade immune responses through complex cytokine signaling. Cytokine antibody arrays reveal how tumor, stromal, and immune cells interact to promote tumor survival and spread, informing new antitumor therapies.

Area of Science:

  • Immunology
  • Cancer Biology
  • Molecular Biology

Background:

  • Tumor cells employ complex immunosuppression mechanisms involving intricate immune cell cross-talk and cytokine signaling.
  • Understanding these mechanisms has been challenging due to the complexity of immune cell development and pleiotropic cytokine effects.

Purpose of the Study:

  • To review the interactions between cancerous, stromal, and immune cells within the tumor microenvironment (TME).
  • To summarize key cytokine signals involved in tumor immune evasion and progression.
  • To discuss the implications of understanding these cell-cell signaling networks for developing novel antitumor therapies.

Main Methods:

  • Utilizing cytokine antibody arrays and other multiplexed immunoassays for high-throughput screening of secreted proteins.
  • Integrating high-content screening with traditional molecular and cell biology techniques.
  • Analyzing complex cell-cell signaling networks within the TME.

Main Results:

  • Tumor immune evasion involves multifaceted cytokine signaling networks contributed by tumor cells, stromal cells, and diverse immune cell types.
  • These signals are crucial for tumors to survive immune surveillance in a dormant state or to escape and proliferate.
  • Probing TME signaling networks with cytokine screens has significantly advanced the understanding of tumor-immune interactions.

Conclusions:

  • The tumor microenvironment is a complex ecosystem with intricate cytokine-mediated communication essential for tumor immune evasion.
  • Targeting these specific cytokine signals offers promising avenues for developing effective antitumor therapies.
  • Further research into TME signaling networks is critical for overcoming tumor immunosuppression.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

2.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K